These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 38033

  • 1. Biochemical methods for predicting the occurrence of tardive dyskinesia.
    Bürki HR.
    Commun Psychopharmacol; 1979; 3(1):7-15. PubMed ID: 38033
    [No Abstract] [Full Text] [Related]

  • 2. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U, Herrera-Marschitz M, Forster C.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [Abstract] [Full Text] [Related]

  • 3. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML, Trabucchi M.
    Prog Clin Biol Res; 1980 Apr; 39():181-93. PubMed ID: 6105670
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Homovanilic acid accumulation in the brain of rats as a possible cause of the inhibitory action of psychotropic substances on behavior and motor activity].
    Zharkovskiĭ AM, Allikmets LKh.
    Farmakol Toksikol; 1979 Apr; 42(5):467-70. PubMed ID: 39774
    [Abstract] [Full Text] [Related]

  • 6. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M, Shibata R, Murata M, Tanii Y.
    Biol Psychiatry; 1995 Apr 01; 37(7):487-90. PubMed ID: 7786966
    [No Abstract] [Full Text] [Related]

  • 7. Is there a presynaptic tardive dyskinesia?
    Bowers MB, Glazer WM.
    J Clin Psychopharmacol; 1987 Feb 01; 7(1):57-9. PubMed ID: 2880877
    [No Abstract] [Full Text] [Related]

  • 8. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M, Chopra K, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1473-8. PubMed ID: 18554768
    [Abstract] [Full Text] [Related]

  • 9. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW, Clemens JA, Hynes MD.
    J Clin Psychopharmacol; 1982 Dec 01; 2(6):371-5. PubMed ID: 7174859
    [Abstract] [Full Text] [Related]

  • 10. Effect of a reduction in brain 5-hydroxytryptamine on the concentration of homovanillic acid in the rat caudate nucleus [proceedings].
    Fuenmayor L, Vogt M.
    Br J Pharmacol; 1978 Jun 01; 63(2):391P. PubMed ID: 667465
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
    Tripodianakis J, Markianos M, Garelis E.
    Biol Psychiatry; 1983 Mar 01; 18(3):337-45. PubMed ID: 6132625
    [Abstract] [Full Text] [Related]

  • 14. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL, Diamond BI.
    Adv Biochem Psychopharmacol; 1980 Mar 01; 24():359-61. PubMed ID: 6105786
    [No Abstract] [Full Text] [Related]

  • 15. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment.
    Zhang Y, Xu H, He J, Yan B, Jiang W, Li X, Li XM.
    Neurosci Lett; 2007 Jun 08; 420(1):66-71. PubMed ID: 17466452
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Experimental tardive dyskinesia.
    Gunne LM, Häggström JE.
    J Clin Psychiatry; 1985 Apr 08; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M, Chopra K, Kulkarni SK.
    Pharmacol Biochem Behav; 2008 Feb 08; 88(4):511-22. PubMed ID: 18022680
    [Abstract] [Full Text] [Related]

  • 19. [What is the connection between Parkinson disease and tardive dyskinesia?].
    Gunne LM, Andrén PE.
    Lakartidningen; 1994 Aug 24; 91(34):2953-5. PubMed ID: 7990538
    [No Abstract] [Full Text] [Related]

  • 20. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M, Chopra K, Kulkarni SK.
    Fundam Clin Pharmacol; 2007 Oct 24; 21(5):521-9. PubMed ID: 17868205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.